- Home
- AAL vs ALKS Comparison
AAL vs ALKS Comparison
Compare AAL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAL | ALKS |
|---|---|---|
| Founded | 1930 | 1987 |
| Country | United States | Ireland |
| Employees | 133700 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.7B |
| IPO Year | 2004 | 2012 |
Fundamental Metrics
Financial Performance| Metric | AAL | ALKS |
|---|---|---|
| Price | $13.79 | $48.27 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 14 |
| Target Price | $15.59 | ★ $43.43 |
| AVG Volume (30 Days) | ★ 58.2M | 1.6M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $54,633,000,000.00 | $1,475,899,000.00 |
| Revenue This Year | $12.17 | $24.26 |
| Revenue Next Year | $4.62 | $4.47 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 0.78 | N/A |
| 52 Week Low | $10.09 | $25.17 |
| 52 Week High | $18.79 | $55.67 |
Technical Indicators
Market Signals| Indicator | AAL | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 42.20 |
| Support Level | $13.22 | $47.66 |
| Resistance Level | $14.17 | $51.25 |
| Average True Range (ATR) | 0.42 | 1.46 |
| MACD | -0.20 | -0.20 |
| Stochastic Oscillator | 8.02 | 3.22 |
Price Performance
Historical ComparisonAbout AAL American Airlines Group Inc.
American Airlines is the world's largest airline by aircraft, capacity, and scheduled revenue passenger miles. Its major US hubs are Dallas/Fort Worth, Charlotte, Chicago, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C. It generates over 30% of US airline revenue connecting Latin America with destinations in the United States. After completing a major fleet renewal, the company has the youngest average fleet of US legacy carriers.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.